Sport and Aortic valve disease
|
|
|
- Domenic Flowers
- 9 years ago
- Views:
Transcription
1 Sport and Aortic valve disease JESFC 2014 Frédéric SCHNELL Service de Médecine du Sport CHU Rennes Laboratoire de Physiologie Université Rennes 1 INSERM U 1099
2 Prevalence in athletes? Valvular regurgitation more frequent in athletes At least one regurgitant > 90% ; 3-valve regurgitation in 20% Majority = trivial regurgitant volume => no clinical significance Douglas PS, Prevalence of multivalvular regurgitation in athletes. Am J Cardiol, 1989 Aortic Stenosis 2.5 % sudden death in young athletes Maron, The Heart of Trained Athletes, Circ 2006 Bicuspide Valve Same prevalence as in general population = 2.5% Stefani L, Bicuspid aortic valve in competitive athletes, Br J Sports Med 2008
3 Risks of sport in valvular disease? Little is known about the influence of sport on the progression of valvular disease Increase of cardiac output at exercise progression of the valvulopathy? no current scientific data Brutal hemodynamic inadaptation at exercise Arrhythmia Desadaptation of the cardiac pump Parker MW, exercise in valvular heart disease: risks and benefits. Prog Cardio Dis 2011
4 Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, EurCardPrev Rehab 2008 Severity? Clinical, ECG, echocardiography ACC AHA guidelines for the management of patients with valvular heart disease, JACC 2006 Vahanian, Guidelines on the management of valvular Heart Disease, Eur Heart J Athlete: CPET / exercise echo ± Holter-ECG Intensity? Competitive/leissure-time Mitchell sport classification Recommendations for sports participation Maron, 36th Bethesda conference, Eligibility Recommendations for competitive athletes with cardiovascular abnormalities, JACC 2005 Pelliccia, Recommendations for competitive sports participation in athletes with cardiovascular disease, EHJ 2005
5 Bicuspid aortic valve Prevalence = 2.5% Valvular Complications : Aortic Stenosis Aortic Regurgitation Aortic dilatation: > 20-21mm/m 2 Disorders of vascular connective tissue «Recommendations are based on limited data but with the understanding that aortic dissection can occur with aortic root diameters < 50 mm» Stefani L, Bicuspid aortic valve in competitive athletes, Br J Sports Med 2008 Maron, 36th Bethesda conference, JACC 2005
6 Bicuspid aortic valve Criteria for eligibility Recommendations Follow-up no aortic root dilatation < 40 mm* + no significant AS or AR dilated aortic root mm ** all competitive sports classes IA, IB, IIA, and IIB No sports with potential for body collision or trauma 6 months dilated aortic root > 45 mm *** class IA 6 months * < 21 cm/m 2 ; ** mm/m 2 ; *** > 23.5 mm/m 2 Multimodality imaging for the Aorta: CT, MRI Maron, 36th Bethesda conference, Eligibility Recommendations for competitive athletes with cardiovascular abnormalities, JACC 2005
7 Aortic regurgitation Asymptomatic for many years Sudden death rare among asymptomatic patients (<0.2%/year) Unclear how competitive exercise training affects prognosis: Dynamic exercises acutely increases heart rate = shortens diastole time available for aortic regurgitation regular endurance training induces bradycardia = prolongs AVR and may induce LV dysfunction Static exertion can worsen regurgitation by increasing afterload acutely Carabello BA. Progress in mitral and aortic regurgitation. Curr Probl Cardiol 2003;28: ACC AHA guidelines for the management of patients with valvular heart disease, JACC 2006
8 Aortic regurgitation Evaluation Criteria for eligibility Recommendations Follow-up History, PE, ECG, ET, Echo Mild-to-moderate regurgitation, normal LV size and function, normal exercise testing, no significant arrhythmia Mild-to-moderate regurgitation, proof of progressive LV dilatation Mild-to-moderate regurgitation, significant ventricular arrhythmia at rest or under stress AVR and dilatation of the ascending aorta (>50mm) All sports Class IA No competitive sports No competitive sports 6 months Severe regurgitation No competitive sports Mild=absence of peripheral signs of AVR and normal LV -and atrial size and function; small dimension of the diastolic flow signal on Doppler echocardiography. Moderate=peripheral signs of AVR, mild-to-moderate enlargement of the LV, normal systolic function, moderate dimension of the diastolic flow signal on Doppler echo. Severe=peripheral signs of AVR, marked dilatation of the LV and/or evidence of LV dysfunction; enlarged atrial size and large dimension of the diastolic flow signal on Doppler echo Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008
9 Aortic regurgitation Evaluation: Pitfalls in athletes LV end-diastolic size is increased in the healthy athlete => should be considered when assessing LV size in AR Professional Rugby Player H= 1.95m - W=123kg BSA=2,54m 2 LVDd: 23,7 mm/m 2 LVEDd: 60mm - LVESd 42mm
10 Aortic Stenosis Sudden death is more frequent in symptomatic patients with severe AS May occur in completely asymptomatic patients Is rare with mild AS Present in 2.5% of young athletes with SCD In patients with AS exercise induces a markedly elevated cardiac output or peripheral vascular resistance => exaggerated valvular gradient and a marked increase in LV systolic pressure Rosenhek R, Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000 Maron, The Heart of Trained Athletes : Cardiac Remodeling and the Risks of Sports, Including Sudden Death Cir 2006
11 Aortic Stenosis Evaluation Criteria for eligibility Recommendations Follow-up History, PE, ECG, ET, Echo Mild stenosis normal LV size and function at rest and under stress no symptoms, no significant arrhythmia Low-moderate dynamic, low-moderate static (I A,B + II A, B) Moderate stenosis normal LV function at rest and under stress Low dynamic and low static (IA) Moderate stenosis LV dysfunction at rest or under stress, or marked LV hypertrophy (>15 mm) No competitive sports Severe stenosis No competitive sports Symptomatic patients with significant AVS Surgery Mild=AVA > 1.5 cm 2, mean gradient 20mmHg / Moderate=AVA of cm 2, mean gradient mmhg / Severe=AVA <1.0 cm 2, mean gradient 50mmHg. Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008
12 Aortic Prosthesis Insufficient data to determine whether sport has any longlasting effect on ventricular or prosthetic valve function Reduced effective valve areas Exercise: elevated valve gradients and reduced cardiac outputs / normally expected Evaluate at rest and during exercise using stress echo to the level of exercise the athlete wishes to pursue Maron, 36th Bethesda conference, Eligibility Recommendations for competitive athletes with cardiovascular abnormalities, JACC 2005 Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008
13 Aortic Prosthesis Ao valve Evaluation Criteria for eligibility Recommendations Followup Bioprosthetic History, PE, ECG, ET, Echo Normal valve function + normal LV function + stable sinus rhythm I A,B + II A, B AF and anticoagulation + No contact sports Prosthetic (artificial) Normal valve function + normal LV function + anticoagulation I A,B + II A, B No contact types of sport Mellwig, Recommendations for the management of individuals with acquired valvular heart disease who are involved in leissure-time physical activities or competitive sports, Eur Card Prev Rehab 2008
14 Conclusion «Physicians with knowledge of an individual athlete severity of the lesion + physiological + psychological response to competition may liberalize these recommendations in selected instances» «The recommendations are for athletes who are asymptomatic» «Exercise testing is useful in confirming normal effort tolerance and suitability for the proposed athletic activity»
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular
Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip
Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity
Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity Jean-Luc MONIN, MD, PhD Henri Mondor University Hospital Créteil, FRANCE Disclosures : None 77-year-old woman, mild dyspnea
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
5. Management of rheumatic heart disease
5. Management of rheumatic heart disease The fundamental goal in the long-term management of RHD is to prevent ARF recurrences, and therefore, prevent the progression of RHD, and in many cases allow for
HEART HEALTH WEEK 3 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease HEART FAILURE. Relatively mild, symptoms with intense exercise
WEEK 3 SUPPLEMENT HEART HEALTH A Beginner s Guide to Cardiovascular Disease HEART FAILURE Heart failure can be defined as the failing (insufficiency) of the heart as a mechanical pump due to either acute
Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery
Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Srinivasan Rajagopal M.D. Assistant Professor Division of Cardiothoracic Anesthesia Objectives Describe the pathophysiology
Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease
Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University
Dysfunction of aortic valve prostheses
Dysfunction of aortic valve prostheses Kai Andersen Oslo University Hospital Rikshospitalet, Norway Dysfunction of aortic valve prostheses Kai Andersen Oslo University Hospital Rikshospitalet, Norway No
Section Four: Pulmonary Artery Waveform Interpretation
Section Four: Pulmonary Artery Waveform Interpretation All hemodynamic pressures and waveforms are generated by pressure changes in the heart caused by myocardial contraction (systole) and relaxation/filling
EAE TEACHING COURSE Aorta and aortic valve 2012
EAE TEACHING COURSE Aorta and aortic valve 2012 31th March 2012 Szczecin, Poland EP EAE TEACHING COURSE: aorta and aortic valve Szczecin, 31st March 2012 Prof. Luigi Badano, Italy Prof. Patrizio Lancellotti,
RACE I Rapid Assessment by Cardiac Echo. Intensive Care Training Program Radboud University Medical Centre NIjmegen
RACE I Rapid Assessment by Cardiac Echo Intensive Care Training Program Radboud University Medical Centre NIjmegen RACE Goal-directed study with specific questions Excludes Doppler ultrasound Perform 50
How To Treat Aortic Stenosis
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Developed in Collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, Society
The P Wave: Indicator of Atrial Enlargement
Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Health Sciences, College of 8-12-2010 The P Wave: Indicator of Atrial Enlargement Patrick Loftis
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI
Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated
Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469)
Provider Checklist-Outpatient Imaging Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Medical Review Note: Per InterQual, if any of the following are present,
Aortic Valve Stenosis and CAD
EUROECHO 14, Copenhagen 2010 Aortic Valve Stenosis and CAD Aleksandar N. Neskovic Clinical Hospital Center Zemun Belgrade University School of Medicine Aortic Stenosis and CAD Important facts Links AS/CAD
HISTORY. Questions: 1. What diagnosis is suggested by this history? 2. How do you explain her symptoms during pregnancy?
HISTORY 33-year-old woman. CHIEF COMPLAINT: months duration. Dyspnea, fatigue and nocturnal wheezing of six PRESENT ILLNESS: At ages 5 and 9, she had migratory arthritis. At age 29, in the third trimester
Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust
Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia
Potential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
How to read the ECG in athletes: distinguishing normal form abnormal
How to read the ECG in athletes: distinguishing normal form abnormal Antonio Pelliccia, MD Institute of Sport Medicine and Science www.antoniopelliccia.it Cardiac adaptations to Rowing Vagotonia Sinus
1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA
1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate
INHERIT. The Lancet Diabetes & Endocrinology In press
INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy a Randomized Intervention Trial with losartan Anna Axelsson, Kasper Iversen, Niels Vejlstrup, Carolyn
38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD.
Stress Testing: Wael A. Jaber, MD,FACC 38 year old female with mild obesity She is planning an exercise program to loose weight. She has no other known risk factors for CAD. You recommend: A. Exercise
Diagnostic and Therapeutic Procedures
Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
INTRODUCTION TO EECP THERAPY
INTRODUCTION TO EECP THERAPY is an FDA cleared, Medicare approved, non-invasive medical therapy for the treatment of stable and unstable angina, congestive heart failure, acute myocardial infarction, and
NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
Note: The left and right sides of the heart must pump exactly the same volume of blood when averaged over a period of time
page 1 HEART AS A PUMP A. Functional Anatomy of the Heart 1. Two pumps, arranged in series a. right heart: receives blood from the systemic circulation (via the great veins and vena cava) and pumps blood
Perioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,
How To Understand What You Know
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology
Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes
Valve Disease and Diastology Summit
Heart & Vascular Institute Valve Disease and Diastology Summit is offered in cooperation with the American Society of Echocardiography. Valve Disease and Diastology Summit March 4 6, 2016 Eden Roc Hotel
Doc, I Am Fine, But I Have A Cardiac Condition
Doc, I Am Fine, But I Have A Cardiac Condition Nevine Mahmoud, MD John Ludtke, MD Maj, USAFR, MC, FS RAM Class 2014 Wright State University Boonshoft School of Medicine Division of Aerospace Medicine Dayton,
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b
Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy Statement: Percutaneous
Atrial Fibrillation and Heart Failure: A Cause or a Consequence
Atrial Fibrillation and Heart Failure: A Cause or a Consequence Rajat Deo, MD, MTR Assistant Professor of Medicine Division of Cardiology, Electrophysiology Section University of Pennsylvania November
Electrocardiographic Issues in Williams Syndrome
Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital
Fellow TEE Review Workshop Hemodynamic Calculations 2013. Director, Intraoperative TEE Program. Johns Hopkins School of Medicine
Fellow TEE Review Workshop Hemodynamic Calculations 2013 Mary Beth Brady, MD, FASE Director, Intraoperative TEE Program Johns Hopkins School of Medicine At the conclusion of the workshop, the participants
Dr Richard Telford. Introduction
Dr Richard Telford Valvular Heart Disease 1. You visit a patient who is due to have an orthopaedic procedure. He tells you he gets occasional chest pain and shortness of breath on exertion. You notice
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
Guidelines on the management of valvular heart disease
European Heart Journal doi:10.1093/eurheartj/ehl428 Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Heart valve repair and replacement
16 Heart valve repair and replacement 222 Valvular heart disease can be treated in a variety of ways: valve replacement, in which an artificial (prosthetic) heart valve is implanted surgically to replace
5. Diagnosis and management of rheumatic heart disease
5. Diagnosis and management of rheumatic heart disease Introduction Chronic rheumatic valvular heart disease is the long-term result of ARF. It is a disease of poverty and disadvantage. In Australia, the
Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
How should we treat atrial fibrillation in heart failure
Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 23/24 Ottobre 2015 How should we treat atrial fibrillation in heart failure Matteo Anselmino Dipartimento Scienze Mediche Città
Workshop B: Essentials of Neonatal Cardiology and CHD Anthony C. Chang, MD, MBA, MPH CARDIAC INTENSIVE CARE
SHUNT LESIONS NEONATAL : CONGENITAL CARDIAC MALFORMATIONS AND CARDIAC SURGERY ANTHONY C. CHANG, MD, MBA, MPH CHILDREN S HOSPITAL OF ORANGE COUNTY ATRIAL SEPTAL DEFECT LEFT TO RIGHT SHUNT INCREASED PULMONARY
Normal & Abnormal Intracardiac. Lancashire & South Cumbria Cardiac Network
Normal & Abnormal Intracardiac Pressures Lancashire & South Cumbria Cardiac Network Principle Pressures recorded from catheter tip Electrical transducer - wheatstone bridge mechanical to electrical waveform
Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto
Resuscitation in congenital heart disease Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto Evolution of Congenital Heart Disease Extraordinary success: Overall
TAVR: A New Treatment Option for Aortic Stenosis. Alexis Auger, MSN, NP-BC
TAVR: A New Treatment Option for Aortic Stenosis Alexis Auger, MSN, NP-BC 22nd Annual Northeast Regional Nurse Practitioner Conference May 6-8, 2015 DISCLOSURES There has been no commercial support or
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
Non Invasive Testing for CAD
Non Invasive Testing for CAD Wael A. Jaber, MD Section of Cardiac Imaging Heart and Vascular Institute Cleveland Clinic 38 year old female with mild obesity She is planning an exercise program to loose
Hydrodynamic characteristics of prosthetic heart valves Cardiamed
Hydrodynamic characteristics of prosthetic heart valves Cardiamed Hydrodynamic characteristics of blood flow passing through a prosthetic heart valve have profound effect on the activation of thrombus
ECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
Exchange solutes and water with cells of the body
Chapter 8 Heart and Blood Vessels Three Types of Blood Vessels Transport Blood Arteries Carry blood away from the heart Transport blood under high pressure Capillaries Exchange solutes and water with cells
CARDIAC RISKS OF NON CARDIAC SURGERY
CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management
Aortic Stenosis and Comorbidities: the clinical challenge. P. Faggiano Cardiology Division Spedali Civili, Brescia - Italy
Aortic Stenosis and Comorbidities: the clinical challenge P. Faggiano Cardiology Division Spedali Civili, Brescia - Italy 1 Factors affecting decision-making in patients with symptomatic severe aortic
Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
Anatomi & Fysiologi 060301. The cardiovascular system (chapter 20) The circulation system transports; What the heart can do;
The cardiovascular system consists of; The cardiovascular system (chapter 20) Principles of Anatomy & Physiology 2009 Blood 2 separate pumps (heart) Many blood vessels with varying diameter and elasticity
Heart Disease: Diagnosis & Treatment
How I Treat Cardiology Peer Reviewed Heart Disease: Diagnosis & Treatment Amara Estrada, DVM, DACVIM (Cardiology) University of Florida Background Clinical heart disease is the stage of disease when a
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology
Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011
Pre-Operative Cardiac Evaluation Kalpana Jain, MD
Pre-Operative Cardiac Evaluation Kalpana Jain, MD Cardiac evaluation is an integral part of pre-op evaluation. Perioperative cardiac events are common causes of mortality. Major cardiac complications associated
Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013
Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation Michael Acker, MD For the CTSN Investigators AHA November 2013 Acknowledgements Supported by U01 HL088942 Cardiothoracic
Question 1: Interpret the rhythm strip above (comment on regularity, rate, P wave, PR interval and QRS)?
It is your first month on your NICU rotation and you are prerounding on your patients. The nurse takes you aside and says she s been seeing something funny on the cardiac monitor. You walk to the bedside
Mitral valve repair current Status and the modern Sternotomy
Mitral valve repair current Status and the modern Sternotomy David L Saint MD, FACS Tallahassee Memorial Hospital Clinical Assistant Professor Florida State University School of Medicine History of Mitral
2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.
DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Accepted Manuscript 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Rick A. Nishimura, MD, MACC, FAHA Catherine M. Otto, MD, FACC, FAHA Robert O. Bonow, MD, MACC, FAHA
1 Congestive Heart Failure & its Pharmacological Management
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructor: Prof. Keith Baker 1 Congestive Heart Failure & its Pharmacological Management Keith Baker, M.D., Ph.D.
Focused Transthoracic Echocardiography by Sports Medicine Physicians
ORIGINAL RESEARCH Focused Transthoracic Echocardiography by Sports Medicine Physicians Measurements Relevant to Hypertrophic Cardiomyopathy Eugene S. Yim, MD, MPH, Edward F. Gillis, RDCS, Krystin Ojala,
Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
Acute heart failure may be de novo or it may be a decompensation of chronic heart failure.
Management of Acute Left Ventricular Failure Acute left ventricular failure presents as pulmonary oedema due to increased pressure in the pulmonary capillaries. It is important to realise though that left
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.
PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1
National Imaging Associates, Inc. Clinical guidelines
National Imaging Associates, Inc. Clinical guidelines Original Date: February 2010 STRESS ECHOCARDIOLOGY Page 1 of 15 CPT Codes: 93350, 93351, + 93352 Last Reviewed Date: June 2012 Guideline Number: NIA_CG_026
Equine Cardiovascular Disease
Equine Cardiovascular Disease 3 rd most common cause of poor performance in athletic horses (after musculoskeletal and respiratory) Cardiac abnormalities are rare Clinical Signs: Poor performance/exercise
Teaching Med-5 Students Point-of-Care Transthoracic Echocardiography
Teaching Med-5 Students Point-of-Care Transthoracic Echocardiography Anthony M.-H. Ho, Lester A. H. Critchley, Patricia Kan, Sylvia Au, Siu Keung Ng, Simon K. C. Chan, Philip Lam, Gordon Choi, Alex Lee,
Madeline M. Mimi O Donnell, DNP, RN (W) (617) 643-7846 [email protected]
Madeline M. Mimi O Donnell, DNP, RN (W) (617) 643-7846 [email protected] Education: 2009 Doctor of Nursing Practice, MGH Institute of Health Professions, Charlestown, MA. 1994 Post-Masters Certificate
How do you decide on rate versus rhythm control?
Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study
CTA OF THE EXTRACORONARY HEART
CTA OF THE EXTRACORONARY HEART Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland NO DISCLOSURES [email protected] CARDIAC CASE DISTRIBUTION Coronary CTA 30% ED chest
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY
BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology
Anaesthesia and Heart Failure
Anaesthesia and Heart Failure Andrew Baldock, Specialist Registrar, Southampton University Hospitals NHS Trust E mail: [email protected] Self-assessment The following true/false questions may be
on behalf of the AUGMENT-HF Investigators
One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39
Management of ATRIAL FIBRILLATION in general practice 22 BPJ Issue 39 What is atrial fibrillation? Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in primary care. It is often
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC
Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC The Federal Motor Carrier Safety Administration (FMCSA) administers the Federal Motor Carrier Safety Regulations (FMCSRs)
Objectives. The ECG in Pulmonary and Congenital Heart Disease. Lead II P-Wave Amplitude during COPD Exacerbation and after Treatment (50 pts.
The ECG in Pulmonary and Congenital Heart Disease Gabriel Gregoratos, MD Objectives Review the pathophysiology and ECG signs of pulmonary dysfunction Review the ECG findings in patients with: COPD (chronic
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It?
The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It? Indiana Chapter-ACC 17 th Annual Meeting Indianapolis, Indiana October 19, 2013 Deepak Bhakta MD FACC FACP FAHA FHRS CCDS Associate
Read It, Code It, See It
Read It, Code It, See It Richard L. Prager, M.D. University of Michigan Ann Arbor, Michigan Dorothy Latham, R.N. Port Huron Hospital Port Huron, Michigan Nothing to Disclose Disclosure Preoperative diagnosis:
Auscultation of the Heart
Review of Clinical Signs uscultation of the Heart Series Editor: Bernard Karnath, MD Bernard Karnath, MD William Thornton, MD uscultation of the heart can provide clues to the diagnosis of many cardiac
